Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 7, 2005; 11(33): 5142-5150
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5142
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5142
Figure 1 Trans-10,cis-12 (t10c12) CLA abrogates the growth stimulatory effect of heregulin (HRG )-β.
HT-29 cells were plated in 24-well plates at 50000 cells/well in DMEM/F12 supplemented with 10% fetal bovine serum. A day later, the monolayers were serum-starved with serum-free DMEM/F12 supplemented with 5 μg/mL transferrin, 0.1 mg/mL BSA, and 5 ng/mL selenium for 24 h. After serum-starvation, cells were incubated in serum-free medium in the absence or presence of 4 μmol/L t10c12 (A) or c9t11 (B) with or without 20 ng/mL HRG-β. Cell numbers were estimated by the MTT assay. Each bar represents the mean±SE (n = 6). Comparisons between groups that yielded significant differences are indicated by different letters above each bar. For example, aP<0.05 vs 0 μmol/L t10c12, cP<0.05 vs 0 μmol/L t10c12 + HRGβ, eP<0.05 vs 4 μmol/L t10c12.
- Citation: Cho HJ, Kim WK, Jung JI, Kim EJ, Lim SS, Kwon DY, Park JHY. Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells. World J Gastroenterol 2005; 11(33): 5142-5150
- URL: https://www.wjgnet.com/1007-9327/full/v11/i33/5142.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i33.5142